Yuetiva Deming, Ph.D.

Affiliations: 
2011-2018 Department of Psychiatry Washington University School of Medicine, St. Louis, MO, United States 
 2018- Department of Medicine University of Wisconsin, Madison, Madison, WI 
Area:
Genetics, Neuroscience
Google:
"Yuetiva Deming"
Mean distance: (not calculated yet)
 

Parents

Sign in to add mentor
Krista M. Rodgers research assistant 2009-2011 CU Boulder
 (I was an undergraduate research assistant)
Carlos Cruchaga grad student 2011-2017 Washington University School of Medicine
Barbara B. Bendlin post-doc 2018- UW Madison
Corinne D. Engelman post-doc 2018- UW Madison (Epi Tree)
Carlos Cruchaga post-doc 2017-2018 Washington University School of Medicine in St. Louis

Collaborators

Sign in to add collaborator
Logan C. Dumitrescu collaborator 2017- Vanderbilt (Computational Biology Tree)
Michael Ewers collaborator 2017- Ludwig Maximilian University Munich
Christian Haass collaborator 2017- Ludwig Maximilian University Munich
Timothy J. Hohman collaborator 2017- Vanderbilt
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Dumitrescu L, Barnes LL, Thambisetty M, et al. (2019) Sex differences in the genetic predictors of Alzheimer's pathology. Brain : a Journal of Neurology. 142: 2581-2589
Ewers M, Franzmeier N, Suárez-Calvet M, et al. (2019) Increased soluble TREM2 in cerebrospinal fluid is associated with reduced cognitive and clinical decline in Alzheimer's disease. Science Translational Medicine. 11
Li Z, Farias FHG, Dube U, et al. (2019) The TMEM106B FTLD-protective variant, rs1990621, is also associated with increased neuronal proportion. Acta Neuropathologica
Deming Y, Filipello F, Cignarella F, et al. (2019) The gene cluster is a key modulator of soluble TREM2 and Alzheimer's disease risk. Science Translational Medicine. 11
Suárez-Calvet M, Morenas-Rodríguez E, Kleinberger G, et al. (2019) Early increase of CSF sTREM2 in Alzheimer's disease is associated with tau related-neurodegeneration but not with amyloid-β pathology. Molecular Neurodegeneration. 14: 1
Suárez-Calvet M, Capell A, Araque Caballero MÁ, et al. (2018) CSF progranulin increases in the course of Alzheimer's disease and is associated with sTREM2, neurodegeneration and cognitive decline. Embo Molecular Medicine
Maxwell TJ, Corcoran C, Del-Aguila JL, et al. (2018) Genome-wide association study for variants that modulate relationships between cerebrospinal fluid amyloid-beta 42, tau, and p-tau levels. Alzheimer's Research & Therapy. 10: 86
Deming Y, Dumitrescu L, Barnes LL, et al. (2018) Sex-specific genetic predictors of Alzheimer's disease biomarkers. Acta Neuropathologica
Deming Y, Li Z, Benitez BA, et al. (2018) Triggering receptor expressed on myeloid cells 2 (TREM2): a potential therapeutic target for Alzheimer disease? Expert Opinion On Therapeutic Targets
Fernández MV, Budde J, Del-Aguila JL, et al. (2018) Evaluation of Gene-Based Family-Based Methods to Detect Novel Genes Associated With Familial Late Onset Alzheimer Disease. Frontiers in Neuroscience. 12: 209
See more...